Since guanfacine is widely used in long-term pharmacotherapy of ADHD, we aimed to evaluate the possible effects of acute and repeated GF on behavioral and neurophysiological deficits seen in DAT-KO rats. Here, SLC6A3 is linked to attention deficit-hyperactivity disorder.